Instructions
for use

Biopatid

Відгук про Biopatid

Download protocol

Available concentrations

Biopatid KIT 10 mg

Biopatid 40 mg

Biopatid 60 mg

Biopatid

An innovative drug for weight control and metabolism correction, based on the updated Mounjaro formula. Biopatid ensures effective fat burning while preserving muscle mass, allowing desired results to be achieved without health risks.

Composition

Vial contains

Complex of synthetic essential and conditionally essential amino acids:
H-I-L-K-M-F-T-W-V-G-C

Water for injection

Indications for use

Weight management in obesity (as part of the Biopell System weight loss program, as prescribed by a doctor)

Type 2 diabetes mellitus — as an adjunct to diet and exercise.

Contraindications

Hypersensitivity to the drug's components

Pregnancy and lactation

Children under 18 years of age

Severe hepatic or renal insufficiency

Method of administration

Препарат вводиться підшкірно 1 раз на тиждень, в один і той самий день.

Injection sites: abdomen, front of the thigh, upper arm. The injection site should be changed weekly to avoid tissue irritation.

Do not administer intravenously or intramuscularly

Dosing regimen

Important

To ensure correct dosing, use a 100-unit (1 ml) insulin syringe. The dosage is determined individually by a physician based on the clinical situation and the patient's condition.

Набрати до позначки свого флакону

60 mg флакон

60 mg / 2 ml · ~24 ін'єкції

8 units

= 2.5 mg

40 mg флакон

40 mg / 2 ml · ~16 ін'єкцій

12 units

= 2.5 mg

KIT 10 mg флакон

10 mg / 2 ml · ~4 ін'єкції

50 units

= 2.5 mg

підшкірно інсуліновим шприцом (1 ml = 100 Units)

Biopatid KIT 10 mg (vial)

Vial

10 mg / 2 ml

Single dose

from 50u=2.5mg

Frequency

once a week

Administration time

morning/day

Injections per vial

at a dose of 2.5 mg ~ 4 injections

Vials per course

1 vial

Biopatid 40 mg (vial)

Vial

40 mg / 2 ml

Single dose

from 12u=2.5 mg

Frequency

once a week

Administration time

morning/day

Injections per vial

at a dose of 2.5 mg ~ 16 injections

Vials per course

1-4 vials

Biopatid 60 mg (vial)

Vial

60 mg / 2 ml

Single dose

from 8u=2.5 mg

Frequency

once a week

Administration time

morning/day

Injections from 1st vial

at a dose of 2.5 mg ~ 24 injections

Vials per course

1-4 vials

Possible Adverse Reactions

Erythema, itching, induration.

In case of severe reactions, discontinue therapy and provide symptomatic treatment.

Impact on eating behavior

Reducing impulsive overeating

Reducing cravings for fatty or sweet foods

Improving emotional control over appetite

Interactions with other medications

Enhances the effect of hypoglycemic drugs

May alter the absorption rate of oral medications

Metabolic Benefits

Reduction in waist circumference

Improvement in lipid profile

Normalization of blood pressure

Reduction in inflammatory markers (CRP, insulin resistance)

Mechanism of Action

Biopatid is a dual agonist of GIP and GLP-1 receptors, which play a key role in metabolic regulation.

Reduces appetite

Improves insulin sensitivity

Slows gastric emptying

Stabilizes glucose levels

According to clinical studies, administration for 72 weeks provides:

2.5 mg / week

weight loss ~10%

5 mg / week

weight loss ~15%

10 mg / week

weight loss ~20%

15 mg / week

weight loss ~22.5%

90% of patients lost ≥5% of body weight, 60% lost ≥20%

Special Instructions

Biopatid is produced from a high-quality pharmaceutical substance that undergoes a multi-stage purification process with a high degree of purity. To ensure the stability and microbiological safety of the preparation, a specially selected stabilizing medium is used, which maintains the sterility of the solution throughout its entire shelf life.

The entire manufacturing process is carried out:

Under controlled cold conditions

Using 0.22 µm PES membrane filters

With adherence to GMP standards at every stage

This approach ensures a high level of quality, sterility, and safety, which is crucial for the clinical application of the drug in medical practice.

Special Instructions

Blood glucose levels must be monitored.

Patients with chronic diseases should consult a doctor before starting therapy.

Alcohol consumption is not recommended during treatment.

Use with caution in patients with gastrointestinal dysfunction.

Storage conditions

Store at 2–8°C, out of reach of children and protected from light.

Do not freeze.

Once opened, store in the refrigerator for up to 2.5 months.

After transport, store at 2°C–8°C in a dark place.

Shelf life

The shelf life of the NADH product is 24 months from the date of manufacture, provided it is stored at 2–8°C. Do not use after the expiration date indicated on the packaging.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.